Mary Kay Harper
- Biotechnology top 0.2%
- Marine Sponges and Natural Products 49
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis 26
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents 6
- Organic Chemistry top 2%
- Synthetic Organic Chemistry Methods 13
- Chemical synthesis and alkaloids 7
- Cancer Research top 10%
- Synthesis and Biological Activity 23
-
- Chemical Synthesis and Analysis 5
-
- Traditional and Medicinal Uses of Annonaceae 4
- Co-authors
- D. John FaulknerChris M. IrelandTim S. BugniGisela P. ConcepciónEric W. SchmidtGina C. MangalindanLouis R. BarrowsTadeusz F. Molinski
- Cited by
- BiotechnologyPharmacologyToxicology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)PLoS ONE (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- United StatesPhilippinesAustralia
In The Last Decade
Mary Kay Harper
64 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 113
- Biotechnology 1.1k
- Pharmacology 814
- Toxicology 125
- Organic Chemistry 783
- Cancer Research 308
Countries citing papers authored by Mary Kay Harper
This map shows the geographic impact of Mary Kay Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Kay Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Kay Harper more than expected).
Fields of papers citing papers by Mary Kay Harper
This network shows the impact of papers produced by Mary Kay Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Kay Harper. The network helps show where Mary Kay Harper may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary Kay Harper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2021 | 3 | |
| 3 | 2020 | 6 | |
| 4 | 2019 | 20 | |
| 5 | 2018 | 75 | |
| 6 | 2017 | 5 | |
| 7 | 2012 | 15 | |
| 8 | 2011 | 20 | |
| 9 | 2010 | 11 | |
| 10 | 2009 | 17 | |
| 11 | 2009 | 33 | |
| 12 | 2008 | 38 | |
| 13 | 2006 | 58 | |
| 14 | 2006 | 64 | |
| 15 | 2005 | 72 | |
| 16 | 2003 | 18 | |
| 17 | 2002 | 31 | |
| 18 | Localisation of bioactive metabolites in marine sponges | 1999 | 20 |
| 19 | 1998 | 23 | |
| 20 | 1995 | 84 |
About Mary Kay Harper
Mary Kay Harper is a scholar working on Biotechnology, Toxicology and Pharmacology, having authored 64 papers that have together received 2.3k indexed citations. Recurring topics across this work include Marine Sponges and Natural Products (49 papers), Microbial Natural Products and Biosynthesis (26 papers), Synthesis and Biological Activity (23 papers), Synthetic Organic Chemistry Methods (13 papers), Chemical synthesis and alkaloids (7 papers), Bioactive Compounds and Antitumor Agents (6 papers), Chemical Synthesis and Analysis (5 papers) and Traditional and Medicinal Uses of Annonaceae (4 papers). The work is most often cited by research in Biotechnology (1.1k citations), Pharmacology (814 citations) and Toxicology (125 citations). Mary Kay Harper has collaborated with scholars based in United States, Philippines and Australia. Frequent co-authors include D. John Faulkner, Chris M. Ireland, Tim S. Bugni, Gisela P. Concepción, Eric W. Schmidt, Gina C. Mangalindan, Louis R. Barrows, Tadeusz F. Molinski, Deniz Taşdemir and Ryan M. Van Wagoner. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.